Small molecules targeting JAKs--a new approach in the treatment of rheumatoid arthritis. [electronic resource]
Producer: 20130924Description: 1352-7 p. digitalISSN:- 1462-0332
- Administration, Oral
- Aminopyridines
- Antirheumatic Agents -- administration & dosage
- Arthritis, Rheumatoid -- diagnosis
- Clinical Trials, Phase III as Topic
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Forecasting
- Germany
- Humans
- Janus Kinases -- antagonists & inhibitors
- Male
- Maximum Tolerated Dose
- Molecular Targeted Therapy -- methods
- Morpholines
- Oxazines -- administration & dosage
- Piperidines -- administration & dosage
- Prognosis
- Pyridines -- administration & dosage
- Pyrimidines -- administration & dosage
- Pyrroles -- administration & dosage
- Randomized Controlled Trials as Topic
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.